Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.50 |
| ▸ | HPGD | P15428 | 5/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28272111 | 1.00 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL9912659 | 0.84 | ALDH1A1 (0.44) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL2837799 | 0.81 | ALDH1A1 (0.55) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL9912660 | 0.78 | ALDH1A1 (0.54) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL28872577 | 0.77 | ALDH1A1 (0.50) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL3714083 | 0.77 | ALDH1A1 (0.45) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL9057553 | 0.75 | ALDH1A1 (0.47) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL19100108 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL2086850 | 0.72 | CYP1A2 (0.47) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 | |
| SCHEMBL6130354 | 0.72 | ALDH1A1 (0.45) | ALDH1A1HPGDHSD17B10CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109096053-B | Synthesis method of OLED intermediate and semiconductor material 1-hydroxypyrene | 棓诺(苏州)新材料有限公司 | 2021-03-09 | — | — | CN | claimed |
| CN-109096053-A | The synthetic method of OLED intermediate and semiconductor material 1- hydroxyl pyrene | 棓诺(苏州)新材料有限公司 | 2018-12-28 | — | — | CN | claimed |
| EP-0871771-A1 | METHODS AND COMPOSITIONS FOR EFFECTING HOMOLOGOUS RECOMBINATION | YALE UNIVERSITY (US) | 1998-10-21 | — | — | EP | claimed |
| US-5776744-A | BETWEEN A NATIVE NUCLEIC ACID SEGMENT IN A CELL AND A DONOR NUCLEIC ACID SEGMENT INTRODUCED INTO THE CELL | YALE UNIVERSITY (US) | 1998-07-07 | — | — | US | claimed |
| WO-1996041008-A1 | METHODS AND COMPOSITIONS FOR EFFECTING HOMOLOGOUS RECOMBINATION | YALE UNIVERSITY (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996040271-A1 | TREATMENT OF HEMOGLOBINOPATHIES | YALE UNIVERSITY (US) | 1996-12-19 | — | — | WO | claimed |
| JP-55042245-A | — | — | None | — | — | JP | disclosed |
| CN-109096053-B | Synthesis method of OLED intermediate and semiconductor material 1-hydroxypyrene | 棓诺(苏州)新材料有限公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-109096053-B | Synthesis method of OLED intermediate and semiconductor material 1-hydroxypyrene | 棓诺(苏州)新材料有限公司 | 2021-03-09 | — | — | CN | disclosed |
| CN-109096053-A | The synthetic method of OLED intermediate and semiconductor material 1- hydroxyl pyrene | 棓诺(苏州)新材料有限公司 | 2018-12-28 | — | — | CN | disclosed |
| CN-109096053-A | The synthetic method of OLED intermediate and semiconductor material 1- hydroxyl pyrene | 棓诺(苏州)新材料有限公司 | 2018-12-28 | — | — | CN | disclosed |
| US-20100162416-A1 | Multi-stage stem cell carcinogenesis | STEMLIFELINE, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| WO-2010037134-A2 | MULTI-STAGE STEM CELL CARCINOGENESIS | STEMLIFELINE, INC. (US) | 2010-04-01 | — | — | WO | disclosed |
| EP-1176864-A2 | CHEMICAL AND PHYSICAL TREATMENT THAT STIMULATE RECOMBINATION | The University of Chicago (US) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000054574-A2 | CHEMICAL AND PHYSICAL TREATMENT THAT STIMULATE RECOMBINATION | THE UNIVERSITY OF CHICAGO (US) | 2000-09-21 | — | — | WO | disclosed |
| EP-0871771-A1 | METHODS AND COMPOSITIONS FOR EFFECTING HOMOLOGOUS RECOMBINATION | YALE UNIVERSITY (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5776744-A | BETWEEN A NATIVE NUCLEIC ACID SEGMENT IN A CELL AND A DONOR NUCLEIC ACID SEGMENT INTRODUCED INTO THE CELL | YALE UNIVERSITY (US) | 1998-07-07 | — | — | US | disclosed |
| WO-1996041008-A1 | METHODS AND COMPOSITIONS FOR EFFECTING HOMOLOGOUS RECOMBINATION | YALE UNIVERSITY (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996040271-A1 | TREATMENT OF HEMOGLOBINOPATHIES | YALE UNIVERSITY (US) | 1996-12-19 | — | — | WO | disclosed |
| JP-S5542245-A | PRODUCTION OF OPTICAL FIBER | NIPPON TELEGR & TELEPH CORP <NTT> | 1980-03-25 | — | — | JP | disclosed |